A new frontier for smart active implants
Now is an exciting time to be working in the medtech industry, says John Genova, who heads our smart active implants teams. Here, John explains why the next medical frontier is smart active implants.
With technology innovation, pharma can drive targeted delivery and seize market opportunity
Technology innovations are now able to realise health concepts that have been talked about for years. Insurmountable market advantage awaits those that can establish a compelling delivery platform.
The precision medicine industry must work together to transform rare disease treatment
Precision medicine is leading to transformative patient treatments – but industry collaboration is needed to make sure patients with rare diseases are not left behind.
Metamorphosis: How converging deep tech will propel business in the new bioeconomy
Emerging deep tech like biotechnology and synthetic biology are shaping an exciting new bioeconomy. This CC Innovation Briefing offers a vision for its future, and explains how scalable, profitable and resilient bioprocesses will benefit businesses and sustainability.
Drug delivery implant miniaturisation opens doors for disruptive innovation
What does the future of next generation implantable drug delivery devices look like? Harry Moorman believes a CC concept breakthrough in smart, miniaturised active implant innovation offers significant opportunity for a market that is ripe for development and commercial growth…